Project Details
| Status | Active |
|---|---|
| Effective start/end date | 21.04.2016 → 30.06.2026 |
Fields of science
- 302035 Paediatrics and adolescent medicine
REAL 3: A randomised, multinational, active-controlled, (open-labelled), dose finding, (double blinded), parallel group trial investigating efficacy and safety of once-weekly NNC0195-0092 treatment compared to daily growth hormone treatment (Norditropin FlexPro) in growth hormone treatment naive pre-pubertal children with growth hormone deficiency (NCT02616562)
- Wimleitner, Marlene (Researcher)
- Hörtenhuber, Thomas (PI)
Project: Clinical studies › Clinical Study (Industry project)